What Is Hyperdiploid? Causes and Clinical Significance

Hyperdiploid means the cancer cells carry extra chromosomes, more than the normal 46. The word describes the cancer cells only, not the rest of the person’s body. In childhood leukemia it is usually welcome news, because this is the most common and one of the most treatable forms of acute lymphoblastic leukemia (ALL).¹

What Hyperdiploid Means on a Leukemia Report

Normal cells carry 23 pairs of chromosomes, 46 in all, and a karyotype is a picture of them laid out in order. Labs sort the counts into named bands. Cells with 47 to 58 chromosomes are called hyperdiploid.² In childhood ALL, doctors mostly use “high hyperdiploid” for leukemia cells with 51 to 67 chromosomes.³ That high range behaves differently from a count of just one or two extras, which is sometimes called low hyperdiploid.

The extra chromosomes follow a typical pattern. A chromosome may be present in three copies instead of two, or even four.⁴ The extras usually involve chromosomes X, 4, 6, 10, 14, 17, 18 and 21.⁵ Chromosome 21 is gained in nearly every case, often as four copies. So a report listing “+4, +10, +21” is describing this common pattern.

The chromosome line on a report starts with the count, such as 55, then lists the sex chromosomes. A plus sign before a number means an extra copy of that chromosome, and two plus signs for the same number, like +21,+21, mean four copies. If any part of the line is unclear, ask the care team to walk you through it. High hyperdiploid ALL makes up about 30% of childhood B-cell ALL, the commonest type of childhood leukemia.⁶

“Extra chromosomes” is easy to misread. This is not Down syndrome. The extras are only in the leukemia cells, and the child’s healthy cells still have 46 chromosomes.

The number alone also does not tell the whole story. Two reports can both say hyperdiploid yet describe different leukemias, because the count and the particular chromosomes gained both matter. A report may list structural changes or other findings beside the count, and those are read separately. It is not a stage or a measure of how sick the child is at diagnosis.

What Causes Hyperdiploid Leukemia

Normally a dividing cell splits its copied chromosomes evenly into two daughter cells. In hyperdiploid ALL, the best-fitting explanation is a single abnormal division that splits a cell three ways and gives one daughter most of the extras at once.⁷ That cell’s descendants then shift slightly over many generations.⁸ Scientists have proposed several other routes, and no single one explains every tumor.⁹

It often starts before birth. Identical twins both diagnosed with hyperdiploid ALL at age 2 shared the same leukemia cell fingerprint.¹⁰ That means the leukemia most likely began in one twin before birth and passed to the other through their shared placenta.¹¹ For many children, then, the first step happened in the womb, long before any symptoms.

Parents often go back over the pregnancy looking for something they did. The faulty division is a random event inside one developing blood cell, and nothing the parents did during pregnancy has been shown to cause it. Because it starts before birth and causes no signs at first, there was nothing to catch earlier.

Extra chromosomes alone are not enough to cause leukemia. The earliest leukemia cells carry only the extra chromosomes.¹² Later changes, often in genes that tell cells to grow, come on top of that.¹³ About half of cases have a change in one family of growth-signal genes.¹⁴ Usually only one such growth-gene change appears, as if one is enough.¹⁵ A pre-leukemic cell can sit quietly for years, and most such cells never become leukemia without further changes.

Why Hyperdiploid Is Usually Good News in Childhood ALL

High hyperdiploidy is the largest and one of the most favorable groups of childhood ALL.¹⁶ In one large group, children with the best-scoring hyperdiploid leukemia had about 97% event-free survival at 10 years.¹⁷ Its link to longer survival was noticed as far back as 1967.¹⁸

Event-free survival counts anything that interrupts a cure: the leukemia coming back, a second cancer, or death during treatment. It is stricter than overall survival, because a child who relapses but is later cured still counts as having had an event.

Which chromosomes are gained matters. In UK trials, children with extra 17 and/or 18, and without extra 5 and 20, formed a good-risk group.¹⁹ About 4 in 5 hyperdiploid children fell in that group.²⁰ Their chance of relapse, the leukemia coming back, was about 5% at 10 years, versus 16% for the rest.²¹ Overall survival at 10 years was 96% in the good-risk group and 86% in the others.²²

Doctors look at other signals too. Extra copies of 10 and 17 together point to better results than either alone.²³ An extra chromosome 5 is linked to somewhat worse results.²⁴ Children with 54 to 58 chromosomes did better than those with 51 to 53 or 59 to 68.²⁵

These percentages come from large groups of children. They describe how groups did, not what will happen to any single child.

“Poorer risk” within hyperdiploid is less alarming than it sounds. Most children in the less favorable group were still cured, so a lower figure does not mean the odds are bad. It may mean closer monitoring or a slightly stronger treatment plan, and the risk group can change once doctors see how quickly the leukemia clears.

Hyperdiploidy is only one input to the risk group. The child’s age and white blood cell count at diagnosis are also used, and doctors look for other genetic findings in the leukemia cells, since some can outweigh the favorable effect of extra chromosomes.

Useful questions for the oncologist: which chromosomes are gained and how many in total, which risk group your child is in and why, how early treatment response will be measured and used, and whether other genetic findings change the picture.

How Doctors Test for Hyperdiploidy

Karyotyping, which means growing cells and counting their chromosomes under a microscope, is the standard test.²⁶ The cells sometimes fail to grow in the lab.²⁷ So labs also measure the DNA index, the amount of DNA in leukemia cells compared with normal cells.²⁸ A DNA index above 1 means extra DNA, and it needs no growing of cells.²⁹

A value of 1.0 means a normal DNA amount. High hyperdiploid leukemia usually shows a value somewhat above 1.16. The DNA index shows only total extra material, not which chromosomes are responsible, so it cannot replace the karyotype when that is available.

FISH uses glowing probes to check specific chromosomes and gene changes.³⁰ Together with the DNA index and karyotype, it sorts leukemia into standard-risk groups, which include high hyperdiploid, and high-risk groups.³¹ More detailed genetic tests add precision but cost more and are not available everywhere.³²

The lab counts the glowing spots in each cell. Three or four spots for a targeted chromosome where two are expected point to extra copies of it. Because FISH can work on cells that are not dividing, it can give a result when karyotyping is not possible.

For families, samples come from a bone marrow test at diagnosis. Flow DNA index results can come within days, while karyotype results may take longer because the cells must grow. Doctors may confirm or update the risk group as results arrive.

How Hyperdiploidy Affects Leukemia Treatment

In lab tests, hyperdiploid ALL cells were about 9 times more sensitive to mercaptopurine than other ALL cells.³³ They were about 20 times more sensitive to asparaginase.³⁴ Extra chromosomes 14 and 17 link to mercaptopurine sensitivity, and 16 and 17 to asparaginase sensitivity.³⁵

These figures come from laboratory tests on cells. They suggest a reason for good results but do not guarantee how a given child will respond.

In practice, most children are placed on standard or lower-intensity protocols. Treatment is given in phases, usually starting with induction to clear the leukemia from the blood and marrow, followed by consolidation and other intensifying blocks. The long final phase, maintenance, uses milder daily and periodic medicines to keep the leukemia from returning. Standard-risk plans are less intense than high-risk plans, with fewer or lighter drug blocks and often fewer side effects.

Mercaptopurine is usually a daily pill in maintenance, and taking it on schedule matters because these cells respond to it. Treatment still lasts about two to three years overall. Treatment is not shortened just because the outlook is good, since relapse risk is low but not zero.

Hyperdiploidy in Multiple Myeloma and Neuroblastoma

About half of multiple myeloma cases are hyperdiploid, with extra odd-numbered chromosomes such as 3, 5, 7, 9, 11, 15, 17 and 19.³⁶ Myeloma is a cancer of plasma cells in the bone marrow, and the pattern is often found when the marrow is tested at diagnosis. It usually goes with better overall survival.³⁷ The advantage is lost if high-risk changes such as certain chromosome 14 swaps or a 17p loss are also present.³⁸ So the result is judged together with other genetic findings and does not settle the outlook alone. Hyperdiploid myeloma is also linked to more bone disease,³⁹ so patients may be watched closely for bone problems and offered bone-protecting care.

About 65% of neuroblastomas are hyperdiploid.⁴⁰ Neuroblastoma is a childhood cancer that arises from immature nerve cells, and the tumor’s chromosome count is tested on tissue from a biopsy or surgery. Hyperdiploidy goes with earlier-stage disease and good outcomes in babies.⁴¹ In babies under 1 with widespread disease, more than 90% with hyperdiploid tumors had long-term survival, while normal-count tumors did poorly.⁴² The benefit depends on age, shrinking after about 18 months.⁴³ Doctors use the count together with age, stage and other tumor findings to plan treatment, so the same finding in an older child does not carry the same weight.